Lanean...
Intrathecal anti-CD20 efficiently depletes meningeal B cells in CNS autoimmunity
Clinical trials revealed that systemic administration of B-cell-depleting anti-CD20 antibodies can hold lesion formation in the early relapsing-remitting phase of multiple sclerosis (MS). Throughout the secondary-progressive (SP) course of MS, pathogenic B cells may, however, progressively replicate...
Gorde:
Egile Nagusiak: | , , , , , , , , , |
---|---|
Formatua: | Artigo |
Hizkuntza: | Inglês |
Argitaratua: |
BlackWell Publishing Ltd
2014
|
Gaiak: | |
Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4184778/ https://ncbi.nlm.nih.gov/pubmed/25356419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.71 |
Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|